Entera Bio Ltd. — Director's Dealing 2022

Apr 4, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Entera Bio Ltd. (ENTX)
CIK: 0001638097
Period of Report: 2022-03-31

Reporting Person: Galitzer Hillel (Chief Operating Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-31	Stock Option (right to buy)	$2.86	A	60000	Acquired	2032-03-31	Ordinary Shares, par value NIS 0.0000769 per share (60000)	Direct

Footnotes

F1: The options vest over a four-year period that commenced on March 31, 2022, with 25% of the options vesting on the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining three-year period.